SynGen Obtains $5,000,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=266aaac6-80ff-484f-9c5d-3e8e7a25dc35&Preview=1
Date
4/20/2012
Company Name
SynGen
Mailing Address
1919 21st Street Sacramento, CA 95811
Company Description
SynGen enables regenerative cures through innovative engineering. We are in the business of inventing and commercializing products that utilizes single-use sterile plastic cartridge disposables and dedicated, highly automated mechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue.
Website
http://www.syngeninc.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Series A
Proceeds Purposes
We will use these proceeds to accelerate the commercialization of our SynGen-1000 platform product.
M&A Terms
Venture Investor
Bay City Capital